Principal Financial Group Inc Ab Cellera Biologics Inc. Transaction History

Principal Financial Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$4.29 - $5.97 $330,261 - $459,594	-76,984 Reduced 69.24%	34,204 $154,000
Q4 2023 Feb 07, 2024	BUY	$3.91 - $5.93 $71,228 - $108,026	18,217 Added 19.59%	111,188 $634,000
Q3 2023 Nov 02, 2023	BUY	$4.6 - $7.95 $94,070 - $162,577	20,450 Added 28.2%	92,971 $427,000
Q2 2023 Aug 07, 2023	BUY	$5.66 - $7.59 $138,517 - $185,750	24,473 Added 50.93%	72,521 $468,000
Q1 2023 May 09, 2023	SELL	$7.31 - $11.18 $7,185 - $10,989	-983 Reduced 2.0%	48,048 $362,000
Q4 2022 Feb 09, 2023	BUY	$9.48 - $14.52 $226,628 - $347,115	23,906 Added 95.15%	49,031 $496,000
Q3 2022 Nov 09, 2022	BUY	$9.2 - $13.68 $48,042 - $71,436	5,222 Added 26.24%	25,125 $248,000
Q2 2022 Aug 10, 2022	BUY	$5.72 - $10.65 $113,845 - $211,966	19,903 New	19,903 $212,000

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.